Tvardi Therapeutics Inc. (TVRD) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Tvardi Therapeutics Inc.

NASDAQ: TVRD · Real-Time Price · USD
40.23
2.86 (7.65%)
At close: Oct 03, 2025, 3:59 PM
40.55
0.80%
After-hours: Oct 03, 2025, 04:21 PM EDT

Tvardi Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Net Income
-25.57M -45.08M -70.87M -67.54M -83.09M -63.08M -32.38M -28.03M
Depreciation & Amortization
120K 150K 192K 216K 664K 587K 545K 521K
Stock-Based Compensation
707K 1.43M 3.35M 3.43M 3.43M 3.43M 85K n/a
Other Working Capital
-2.06M 782K 5.36M 1.98M 6.82M 4.44M 348K 1.87M
Other Non-Cash Items
4.38M 19.87M 21.52M 16.1M 10.35M 4.99M 3.24M 3.23M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-11.22M -11.53M -15.1M -14.83M 369K -1.77M 3.12M 4.63M
Operating Cash Flow
-31.58M -35.16M -60.92M -62.62M -68.28M -55.85M -25.39M -19.64M
Capital Expenditures
n/a -210K -1.05M -3.1M -3.42M -3.21M -2.38M -323K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-31.49M 32.21M n/a -65M -87.85M -120.06M -87.85M -22.85M
Sales Maturities Of Investments
18.55M 23M 82M 113.85M 157.68M 142.18M 83.18M 46.33M
Other Investing Acitivies
n/a -32.21M -32.21M -32.21M -32.21M n/a n/a n/a
Investing Cash Flow
-12.93M 22.79M 48.74M 13.54M 34.19M 18.9M -7.05M 23.16M
Debt Repayment
-2.31M -1.91M -3.6M 34.48M 35.18M 35.79M 36.47M n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
22.6M -5K -5K -5K -5K n/a n/a n/a
Financial Cash Flow
20.71M -1.91M -3.6M 34.49M 36.3M 36.91M 37.59M 1.12M
Net Cash Flow
-28.59M -12.78M -14.28M -19.37M -4.07M -6.31M -1.12M 4.63M
Free Cash Flow
-31.58M -35.37M -61.96M -63.67M -69.65M -57.01M -25.72M -19.97M